There’s been some interesting research on a compound that appears to be a partner peptide for GLP-1. Oxyntomodulin is released in response to a meal and seems to have a significant effect on glucose levels. Our current PharmD candidate, Farhan Guard, from Lake Erie College of Medicine, found out about this …
Read More »Yearly Archives: 2011
An Eye-Opening Interview with Steven Edelman, MD, PART 2
This week, we present the second half of our publisher Steve Freed’s interview with Dr. Steven Edelman at the recent ADA Scientific Sessions in San Diego. Steve Freed: One of the more exciting things I have read about is the extra eyelet effect on the GLP-1 compounds on the heart …
Read More »GLP-1 Knowledge Survey Part V
Over the past few weeks we have been looking at your colleagues’ responses to questions about GLP-1, including mechanisms, interactions, dosing and effectiveness. Over the next two weeks we will examine some of your opinions on starting doses and selecting patients….
Read More »Oxyntomodulin: Partner to GLP-1?
Oxyntomodulin is a gut peptide released in response to a meal. It is synthesized within specialized enteroendocrine cells called L cells. Oxyntomodulin is released from the intestinal L cells 5-10 minutes after ingestion of food in amounts proportional to calorie intake and levels peak 30 minutes after meals. Oxyntomodulins are …
Read More »Editor’s Note: Anti-inflammatory Steroids and “Hypoglycemia”
There has been a shortage of methylprednisolone and prednisone dose packs available in pharmacies lately and this week’s Disaster Averted deals with what happens when patients get their anti-inflammatory steroids in a bottle instead of a pack. If you’re thinking that the problem is hyperglycemia then you need to review …
Read More »Letter from the Editor #582
The National Committee for Quality Assurance (NCQA) recently held a series of webinars to help clinicians in “Achieving and Outperforming Type 2 Diabetes HEDIS Measures.“ There were a lot of elements that needed to fall into place to make that happen and our Pharm D candidate, Daniel Schultz, listened in …
Read More »Managing Clinical Problems in Diabetes, Case Study #13: Gestational Diabetes
Edited by Trisha Dunning AM, RN, MEd, PhD, CDE, FRCNA and Glenn Ward MBBS, BSc, DPhil (Oxon), FRACP, FRCPath Mrs. ORA was referred to a diabetes educator when she developed diabetes at 29.5 weeks’ gestation. Mrs. ORA is a 30-year-old primigravida and is 29.5 weeks pregnant. She was referred to the …
Read More »Diagnosis and Management of Diabetic Eye Disease, Part 6 of 7
This week’s slides on Diabetic Eye Disease cover the Staging of Diabetic Macular Edema, Referral & Follow-up for DR, Treatment of DR-PRP, Treatment of DR – Vitrectomy, and Treatment of CSME….
Read More »Achieving and Outperforming Type 2 Diabetes HEDIS Measures
A Guide for Managed Care to Provide Clinicians with Tools to Support the Delivery of Consistent High-Quality Care Reviewed by Daniel Schultz, Doctor of Pharmacy Candidate, University of Florida College of Pharmacy The first presentation focused on HEDIS, a widely used set of measurements of healthcare performance …
Read More »Diabetes and Fasting
People fast for many reasons: blood tests, surgery or other kind of procedure, or for religious reasons. The Diabetes and Fasting handout will guide your patients who need to fast with some tips for those on oral meds or insulin. Download Diabetes and Fasting (pdf) here For …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.